用于预测胎盘植入谱系高危女性胎盘侵袭性的MRI评分模型的开发与验证
本研究通过系统综述定量Meta分析提取MRI征象建立预测胎盘植入谱系(PAS)及穿透性胎盘的评分模型,并在2016至2021年连续纳入的294例高危孕妇中验证。PAS模型预测PAS的AUC为0.90,预测不良围产期结局的AUC为0.85;穿透性胎盘模型预测穿透性胎盘的AUC为0.92。作者认为基于Meta分析建立的MRI评分模型可较准确预测PAS、穿透性胎盘及不良围产期结局。
要点
- T2暗带、胎盘/子宫膨隆、T2低信号界面消失、膀胱壁中断、胎盘异质性和胎盘内血管异常与PAS及穿透性胎盘均相关。
- 子宫肌层变薄和局灶性外生性肿块仅与PAS相关。
- PAS模型预测PAS的AUC为0.90(95%CI:0.86,0.93),预测不良围产期结局的AUC为0.85(95%CI:0.79,0.90)。
核心结论
- 基于定量Meta分析建立的MRI评分模型可较准确预测PAS、穿透性胎盘及不良围产期结局,并可能为PAS高危孕妇的管理提供循证风险分层。
研究设计与样本
- 回顾性研究,包括衍生队列和验证队列;衍生队列来自评估MRI征象对高危女性PAS和/或穿透性胎盘诊断性能的已发表研究的系统综述,纳入26项研究共2568例女性;验证队列为2016年至2021年间连续纳入的294例接受胎盘MRI的PAS高危孕妇,其中258例(88%)诊断为PAS;由两名放射科医师独立评估MRI征象,参考标准为术中和病理所见。
关键影像表现/征象
- T2暗带、胎盘/子宫膨隆、T2低信号界面消失、膀胱壁中断、胎盘异质性和胎盘内血管异常与PAS及穿透性胎盘均相关。
- 子宫肌层变薄和局灶性外生性肿块仅与PAS相关。
诊断标准与关键数值
- PAS模型预测PAS的AUC为0.90(95%CI:0.86,0.93)。
- PAS模型预测不良围产期结局的AUC为0.85(95%CI:0.79,0.90)。
- 穿透性胎盘模型预测穿透性胎盘的AUC为0.92(95%CI:0.86,0.98)。
临床应用与阅片要点
- 作者认为这些MRI评分模型有助于准确预测PAS侵袭性,并为PAS高危孕妇的管理提供循证风险分层。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop and validate MRI-based scoring models for predicting placenta accreta spectrum (PAS) invasiveness.
MATERIALS AND METHODS: This retrospective study comprised a derivation cohort and a validation cohort. The derivation cohort came from a systematic review of published studies evaluating the diagnostic performance of MRI signs for PAS and/or placenta percreta in high-risk women. The significant signs were identified and used to develop prediction models for PAS and placenta percreta. Between 2016 and 2021, consecutive high-risk pregnant women for PAS who underwent placental MRI constituted the validation cohort. Two radiologists independently evaluated the MRI signs. The reference standard was intraoperative and pathologic findings. The predictive ability of MRI-based models was evaluated using the area under the curve (AUC).
RESULTS: The derivation cohort included 26 studies involving 2568 women and the validation cohort consisted of 294 women with PAS diagnosed in 258 women (88%). Quantitative meta-analysis revealed that T2-dark bands, placental/uterine bulge, loss of T2 hypointense interface, bladder wall interruption, placental heterogeneity, and abnormal intraplacental vascularity were associated with both PAS and placenta percreta, and myometrial thinning and focal exophytic mass were exclusively associated with PAS. The PAS model was validated with an AUC of 0.90 (95% CI: 0.86, 0.93) for predicting PAS and 0.85 (95% CI: 0.79, 0.90) for adverse peripartum outcome; the placenta percreta model showed an AUC of 0.92 (95% CI: 0.86, 0.98) for predicting placenta percreta.
CONCLUSION: MRI-based scoring models established based on quantitative meta-analysis can accurately predict PAS, placenta percreta, and adverse peripartum outcome.
CLINICAL RELEVANCE STATEMENT: These proposed MRI-based scoring models could help accurately predict PAS invasiveness and provide evidence-based risk stratification in the management of high-risk pregnant women for PAS.
KEY POINTS: • Accurately identifying placenta accreta spectrum (PAS) and assessing its invasiveness depending solely on individual MRI signs remained challenging. • MRI-based scoring models, established through quantitative meta-analysis of multiple MRI signs, offered the potential to predict PAS invasiveness in high-risk pregnant women. • These MRI-based models allowed for evidence-based risk stratification in the management of pregnancies suspected of having PAS.
引用
- Liu Q, Zhou W, Yan Z, et al. Development and validation of MRI-based scoring models for predicting placental invasiveness in high-risk women for placenta accreta spectrum. Eur Radiol. 2023. PMID: 37589907. doi:10.1007/s00330-023-10058-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。